Role of intravenous immunoglobulins in the management of systemic lupus erythematosus: a single-centre experience
Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown aetiology that can affect almost any organ in the body. Although there are no specific guidelines for the use of intravenous immunoglobulin (IG) in the treatment of patients with SLE, it is thought to be an effe...
Saved in:
| Main Authors: | Sedat Yılmaz, Mehmet Nur Kaya, Özlem Kılıç, Muhammet Canbaş, Merve Sungur Özgünen, Ezgi Çimen Güneş |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/11/2/e001402.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Superiority of Compressed Colchicine Tablets over Coated Colchicine Tablets for Familial Mediterranean Fever
by: Mehmet Nur Kaya, et al.
Published: (2024-10-01) -
Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?
by: Ahmet Kaya, et al.
Published: (2024-12-01) -
Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients
by: Anna Wozniacka, et al.
Published: (2003-01-01) -
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
by: Jeet Hemantkumar Patel, et al.
Published: (2020-01-01) -
Clinical correlations of serum anti-dsDNA immunoglobulin subfamilies in patients with systemic lupus erythematosus (SLE)
by: Jing Jing Wang, et al.
Published: (2025-12-01)